Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$119.15 USD
+0.15 (0.13%)
Updated Sep 6, 2024 03:59 PM ET
After-Market: $119.16 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -1.04 |
EPS Last Quarter | -2.05 |
Last EPS Surprise | -33.12% |
ABR | 1.15 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.61 |
Next Year | -3.25 |
EPS (TTM) | -9.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 140.75M | 107.46M | 411.69M | 664.24M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 242.74M | 137.39M | 483.28M | 921.08M |
Low Estimate | 75.62M | 89.10M | 311.62M | 522.35M |
Year ago Sales | 52.02M | 148.62M | 288.27M | 411.69M |
Year over Year Growth Est. | 170.57% | -27.70% | 42.81% | 61.34% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.04 | -1.46 | -6.61 | -3.25 |
# of Estimates | 8 | 6 | 9 | 8 |
Most Recent Consensus | 0.85 | -1.72 | -6.06 | -4.81 |
High Estimate | 0.85 | -0.84 | -4.73 | 1.58 |
Low Estimate | -1.96 | -1.96 | -8.28 | -5.51 |
Year ago EPS | -3.12 | -1.66 | -9.24 | -6.61 |
Year over Year Growth Est. | 66.67% | 12.05% | 28.46% | 50.92% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 0 | 2 | 1 |
Up Last 30 Days | 2 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 1 | 2 | 2 |
Down Last 7 Days | 2 | 4 | 5 | 5 |
Down Last 30 Days | 4 | 5 | 7 | 6 |
Down Last 60 Days | 4 | 5 | 7 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.04 | -1.46 | -6.61 | -3.25 |
7 Days Ago | -1.36 | -0.75 | -5.60 | -1.83 |
30 Days Ago | -1.29 | -0.67 | -5.53 | -1.70 |
60 Days Ago | -1.29 | -0.67 | -5.57 | -1.70 |
90 Days Ago | -1.29 | -0.67 | -5.40 | -1.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.04 | -1.46 | -6.61 | -3.25 |
Zacks Consensus Estimate | -1.04 | -1.46 | -6.61 | -3.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.05 | -2.48 | -1.66 | -3.12 | NA |
Estimate | -1.54 | -1.57 | -2.15 | -2.63 | NA |
Difference | -0.51 | -0.91 | 0.49 | -0.49 | -0.36 |
Surprise | -33.12% | -57.96% | 22.79% | -18.63% | -21.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more